IMC-C225: Phase Ib/IIa data; Phase III

IMCL said that 2.5-year follow-up data from its 15-patient Phase Ib/IIa trial of IMC-C225

Read the full 144 word article

How to gain access

Continue reading with a
two-week free trial.